126 related articles for article (PubMed ID: 31030496)
21. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.
Fishman DA; Cohen L; Blank SV; Shulman L; Singh D; Bozorgi K; Tamura R; Timor-Tritsch I; Schwartz PE
Am J Obstet Gynecol; 2005 Apr; 192(4):1214-21; discussion 1221-2. PubMed ID: 15846205
[TBL] [Abstract][Full Text] [Related]
22. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors].
Smoleń A; Stachowicz N; Czekierowski A; Kotarski J
Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596
[TBL] [Abstract][Full Text] [Related]
23. Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages.
Kotowicz B; Fuksiewicz M; Sobiczewski P; Spiewankiewicz B; Jonska-Gmyrek J; Skrzypczak M; Kowalska M
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():141-6. PubMed ID: 26398337
[TBL] [Abstract][Full Text] [Related]
24. A Predictive Model Using Histopathologic Characteristics of Early-Stage Type 1 Endometrial Cancer to Identify Patients at High Risk for Lymph Node Metastasis.
Bendifallah S; Canlorbe G; Laas E; Huguet F; Coutant C; Hudry D; Graesslin O; Raimond E; Touboul C; Collinet P; Cortez A; Bleu G; Daraï E; Ballester M
Ann Surg Oncol; 2015 Dec; 22(13):4224-32. PubMed ID: 25869227
[TBL] [Abstract][Full Text] [Related]
25. IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients.
Chen YL; Chou CY; Chang MC; Lin HW; Huang CT; Hsieh SF; Chen CA; Cheng WF
Endocr Relat Cancer; 2015 Oct; 22(5):703-11. PubMed ID: 26150382
[TBL] [Abstract][Full Text] [Related]
26. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
Bristow RE; Duska LR; Lambrou NC; Fishman EK; O'Neill MJ; Trimble EL; Montz FJ
Cancer; 2000 Oct; 89(7):1532-40. PubMed ID: 11013368
[TBL] [Abstract][Full Text] [Related]
27. Preoperative measurement of serum C-reactive protein: is it useful in the differential diagnosis of adnexal masses?
Yoshida A; Derchain SF; Pitta DR; Crozatti N; Andrade LALA; da Silva RF; Sarian LO
Int J Biol Markers; 2017 Mar; 32(1):e83-e89. PubMed ID: 27516000
[TBL] [Abstract][Full Text] [Related]
28. Development and Validation of a Prediction Model for Organ-Specific Recurrences After Curative Resection of Colon Cancer.
Nagata H; Ishihara S; Oba K; Tanaka T; Hata K; Kawai K; Nozawa H
Dis Colon Rectum; 2019 Sep; 62(9):1043-1054. PubMed ID: 31318776
[TBL] [Abstract][Full Text] [Related]
29. Ultrasonographic markers and preoperative CA-125 to distinguish between borderline ovarian tumors and stage I ovarian cancer.
Zacharakis D; Thomakos N; Biliatis I; Rodolakis A; Simou M; Daskalakis G; Bamias A; Antsaklis A
Acta Obstet Gynecol Scand; 2013 Mar; 92(3):285-92. PubMed ID: 23193945
[TBL] [Abstract][Full Text] [Related]
30. Preoperative Predictive Factors for Complete Cytoreduction and Survival Outcome in Epithelial Ovarian, Tubal, and Peritoneal Cancer After Neoadjuvant Chemotherapy.
Baek MH; Lee SW; Park JY; Rhim CC; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2017 Mar; 27(3):420-429. PubMed ID: 28187098
[TBL] [Abstract][Full Text] [Related]
31. [Use of multilayer perception artificial neutral networks for the prediction of the probability of malignancy in adnexal tumors].
Smoleń A; Czekierdowski A; Stachowicz N; Kotarski J
Ginekol Pol; 2003 Sep; 74(9):855-62. PubMed ID: 14674136
[TBL] [Abstract][Full Text] [Related]
32. [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].
Jiang W; Feng MY; Dong XY; Dong SM; Zheng JX; Liu XM; Liu WJ; Yan J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):748-754. PubMed ID: 31422613
[No Abstract] [Full Text] [Related]
33. Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma.
de Jong D; Eijkemans MJ; Lie Fong S; Gerestein CG; Kooi GS; Baalbergen A; van der Burg ME; Burger CW; Ansink AC
Oncology; 2007; 72(5-6):293-301. PubMed ID: 18198490
[TBL] [Abstract][Full Text] [Related]
34. External validation of the MR imaging scoring system for the management of adnexal masses.
Ruiz M; Labauge P; Louboutin A; Limot O; Fauconnier A; Huchon C
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():115-9. PubMed ID: 27583370
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a novel predictive scoring model for microvascular invasion in patients with hepatocellular carcinoma.
Zhao H; Hua Y; Dai T; He J; Tang M; Fu X; Mao L; Jin H; Qiu Y
Eur J Radiol; 2017 Mar; 88():32-40. PubMed ID: 28189206
[TBL] [Abstract][Full Text] [Related]
36. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
[TBL] [Abstract][Full Text] [Related]
37. The effect of ovarian imaging on the clinical interpretation of a multivariate index assay.
Goodrich ST; Bristow RE; Santoso JT; Miller RW; Smith A; Zhang Z; Ueland FR
Am J Obstet Gynecol; 2014 Jul; 211(1):65.e1-65.e11. PubMed ID: 24530816
[TBL] [Abstract][Full Text] [Related]
38. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
[TBL] [Abstract][Full Text] [Related]
39. Computed tomography adnexal mass score to estimate risk for ovarian cancer.
Santoso JT; Robinson A; Suganda S; Praservit S; Wan JY; Ueland F
Arch Gynecol Obstet; 2014 Mar; 289(3):595-600. PubMed ID: 23995674
[TBL] [Abstract][Full Text] [Related]
40. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]